Friday, November 20, 2009 - 5:07PM EST

Review Articles

1. Ventilatory management in patients with chronic airflow obstruction.

Author
Koh Y;
Institution
Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Pungnap Dong Songpa-Ku, Seoul 138-736, Korea. yskoh@amc.seoul.kr
Journal
Crit Care Clin. 2007 Apr;23(2):169-81, viii.
Abstract URL
Click here to view abstract

2. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.

Author
Puhan MA; Vollenweider D; Latshang T; Steurer J; Steurer-Stey C;
Institution
Horten Centre, University Hospital of Zurich, Postfach Nord, Zurich, Switzerland. milo.puhan@usz.ch
Journal
Respir Res. 2007 Apr 4;8:30.
Abstract URL
Click here to view abstract

3. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.

Author
Niewoehner DE;
Institution
University of Minnesota, Minneapolis, Minnesota, USA. niewo001@tc.umn.edu
Journal
Am J Med. 2006 Oct;119(10 Suppl 1):38-45.
Abstract URL
Click here to view abstract

4. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.

Author
Tashkin DP;
Institution
Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California 90095-1690, USA. dtashkin@mednet.ucla.edu
Journal
Am J Med. 2006 Oct;119(10 Suppl 1):63-72.
Abstract URL
Click here to view abstract

5. Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events?

Author
Calverley PM; Scott S;
Institution
Clinical Science Centre, University Hospital Aintree, Liverpool, UK. pmacal@liverpool.ac.uk
Journal
COPD. 2006 Dec;3(4):233-42.
Abstract URL
Click here to view abstract

6. N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease.

Author
Sutherland ER; Crapo JD; Bowler RP;
Institution
Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado, USA. sutherlande@njc.org
Journal
COPD. 2006 Dec;3(4):195-202.
Abstract URL
Click here to view abstract

7. Transplantation in chronic obstructive pulmonary disease.

Author
Patel N; Criner GJ;
Institution
Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA. pateln@tuhs.temple.edu
Journal
COPD. 2006 Aug;3(3):149-62.
Abstract URL
Click here to view abstract

8. Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD.

Author
Decramer M; Ferguson G;
Institution
Respiratory Division University Hospital, Katholieke Universiteit Leuven, Leuven, Belgium. marc.decramer@uz.kuleuven.be
Journal
COPD. 2006 Aug;3(3):163-71.
Abstract URL
Click here to view abstract

9. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.

Author
Le Jemtel TH; Padeletti M; Jelic S; Le Jemtel TH; Padeletti M; Jelic S;
Institution
Division of Cardiology, Tulane University, New Orleans, Louisiana 70112-2699, USA. lejemtel@tulane.edu
Journal
J Am Coll Cardiol. 2007 Jan 16;49(2):171-80. Epub 2006 Dec 29.
Abstract URL
Click here to view abstract

10. Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis.

Author
Peytremann-Bridevaux I; Staeger P; Bridevaux PO; Ghali WA; Burnand B; Peytremann-Bridevaux I; Staeger P; Bridevaux PO; Ghali WA; Burnand B; Peytremann-Bridevaux I; Staeger P; Bridevaux PO; Ghali WA; Burnand B;
Institution
Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. Isabelle.Peytremann-Bridevaux@chuv.ch
Journal
Am J Med. 2008 May;121(5):433-443.e4.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9